OrganoGEN Limited is a leading provider of Regenerative Medicine and Orthopedic Medical Devices in Cyprus. Our mission is to enhance patient care by delivering cutting-edge regenerative solutions and high-quality orthopedic products for traumatology and sports medicine.

 

Our Commitment to Innovation and Patient Care

Our team is dedicated to helping patients recover and regain function through innovative regenerative medicine techniques and advanced orthopedic solutions. The human body has a natural ability to heal, but trauma, aging-related diseases, and degenerative conditions can impair this process. We support and enhance natural healing through a multidisciplinary approach, combining Regenerative Medicine, Tissue Engineering, and Orthopedic Technologies to provide effective treatments.

OrganoGEN is a trusted partner of orthopedic surgeons, sports medicine specialists, and medical providers across Cyprus. We are also proud to be official providers of the General Health System (GESY), ensuring wider access to our innovative products and services.

​

Our Expertise and Scientific Approach

Our team consists of highly trained medical professionals, led by our founder and CEO, Dr. Andreas Samourides, a specialist in Regenerative Medicine and Tissue Engineering. With extensive experience in autologous cell therapies and the development of biomimetic scaffolds for skin, tendon, and bone tissue engineering, Dr. Samourides and his team bring unique scientific, clinical, and technical capabilities to the field.

​

At OrganoGEN, we are committed to:
✔ Providing the best regenerative medicine and orthopedic technologies to healthcare professionals.
✔ Ensuring strict quality control over therapeutic products to guarantee safe and effective treatments.
✔ Supporting medical providers with patient-specific treatment consultation and optimized regenerative medicine protocols.
✔ Ethical marketing and transparency, avoiding misleading claims about our products and services.
✔ Driving industry growth through active participation in R&D and clinical innovation.

 

Research, Development & Industry Collaboration

OrganoGEN is actively involved in Research & Development (R&D), focusing on autologous therapeutic agents, synthetic scaffolds (patent pending), and innovative orthopedic solutions. We collaborate with the Cyprus University of Technology, supported by organizations such as the Research & Innovation Foundation of Cyprus and Vet Ex Machina, to develop and validate cutting-edge regenerative medicine and biomaterial technologies in pre-clinical models, paving the way for clinical applications.

​

A Trusted Partner for Medical Providers

We believe that strong collaboration between healthcare professionals is essential for providing high-quality patient care. Our partnerships with surgeons, sports medicine specialists, and orthopedic professionals ensure that patients receive the most effective, science-backed treatments available.

​

Thank you for considering OrganoGEN for your regenerative medicine and orthopedic needs. We are confident that our expertise, innovation, and commitment to patient care can help you achieve the best possible health outcomes.

​

Contact us today to schedule a meeting and explore how we can support your medical practice or recovery journey.